Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.13, 2010-09, pp. : 2269-2271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trials

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2055-2067

Informa Healthcare

Access to resources Recommend Favorite

Exenatide once weekly in type 2 diabetes mellitus

By Bischoff Lindsay A Jabbour Serge A Miller Jeffrey L

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1297-1303

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin

By Forst Thomas Bramlage Peter

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1299-1313

Informa Healthcare

Access to resources Recommend Favorite

Weekly exenatide works wonders for type 2 diabetes

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Is exenatide advancing the treatment of Type 2 diabetes?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 109-112

Informa Healthcare

Access to resources Recommend Favorite